Joseph C. Landolfi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joseph C. Landolfi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Archana Hinduja
Cleveland Clinic Foundation, Cleveland, OH 44195, USA
1 shared publicationDavid Nochlin
JFK Medical Center
1 shared publicationL. Giselle Aguilar
Parkinson’s Disease Center and Movement Disorders Clinic, Baylor College of Medicine
1 shared publicationMangala Nadkarni
1 shared publicationThomas Steineke
JFK Medical Center
1 shared publication
Latest Publications
- 20 November 2008
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 92 (1) , 117-120
Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion
Rosai-Dorfman disease is a rare benign idiopathic histioproliferative disorder usually manifesting as massive painless adenopathy. Extranodal involvement of the Central Nervous System (CNS) mimicking a skull base meningioma is rare. A 42-year-old male presented with painless, progressive left visual loss of 4 months duration. Clinically, he had a left ptosis, proptosis and ophthalmoplegia. Magnetic Resonance Imaging (MRI) of the brain with gadolinium revealed a destructive lesion of the left orbital apex, middle cranial fossa and cavernous sinus. He was treated with corticosteroids and underwent debulking. Pathology showed inflammatory infiltrate in the absence of an infectious agent, emperipolesis and a positive S100 stain was consistent with Rosai-Dorfman disease. As there was no improvement following steroids and debulking, he underwent radiation therapy with significant improvement of his symptoms. Although a rare entity, Rosai-Dorfman disease should be considered in the differential of a skull base lesion.
- 20 November 2008
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 92 (1) , 117-120
Rosai-Dorfman disease manifesting as intracranial and intraorbital lesion
Rosai-Dorfman disease is a rare benign idiopathic histioproliferative disorder usually manifesting as massive painless adenopathy. Extranodal involvement of the Central Nervous System (CNS) mimicking a skull base meningioma is rare. A 42-year-old male presented with painless, progressive left visual loss of 4 months duration. Clinically, he had a left ptosis, proptosis and ophthalmoplegia. Magnetic Resonance Imaging (MRI) of the brain with gadolinium revealed a destructive lesion of the left orbital apex, middle cranial fossa and cavernous sinus. He was treated with corticosteroids and underwent debulking. Pathology showed inflammatory infiltrate in the absence of an infectious agent, emperipolesis and a positive S100 stain was consistent with Rosai-Dorfman disease. As there was no improvement following steroids and debulking, he underwent radiation therapy with significant improvement of his symptoms. Although a rare entity, Rosai-Dorfman disease should be considered in the differential of a skull base lesion.
- 1 July 2003
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 5 (3) , 214-216
Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: Case study
We describe a patient who presented with a clinical syndrome of limbic encephalitis, narcolepsy, and cataplexy. The anti-Ma2 antibody was positive. Although there was no mass on imaging, orchiectomy was performed in this patient, and testicular carcinoma was found. This is the first known case of limbic encephalitis and anti-Ma2 antibody to be associated with cataplexy and possible narcolepsy. Neurological symptoms precede the diagnosis of cancer in 50% of patients with paraneoplastic syndromes, and clinicians are therefore strongly advised to evaluate patients with neurological symptoms for this condition.
- 1 July 2003
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 5 (3) , 214-216
Paraneoplastic limbic encephalitis and possible narcolepsy in a patient with testicular cancer: Case study
We describe a patient who presented with a clinical syndrome of limbic encephalitis, narcolepsy, and cataplexy. The anti-Ma2 antibody was positive. Although there was no mass on imaging, orchiectomy was performed in this patient, and testicular carcinoma was found. This is the first known case of limbic encephalitis and anti-Ma2 antibody to be associated with cataplexy and possible narcolepsy. Neurological symptoms precede the diagnosis of cancer in 50% of patients with paraneoplastic syndromes, and clinicians are therefore strongly advised to evaluate patients with neurological symptoms for this condition.